{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:52:05Z","timestamp":1793749925775,"version":"4.6.1"},"reference-count":197,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jhep.2023.02.033","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T16:16:15Z","timestamp":1678205775000},"page":"538-551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":137,"title":["Role of immune responses in the development of NAFLD-associated liver cancer and prospects for therapeutic modulation"],"prefix":"10.1016","volume":"79","author":[{"given":"Neda","family":"Yahoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3959-6820","authenticated-orcid":false,"given":"Michael","family":"Dudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2983-0414","authenticated-orcid":false,"given":"Percy","family":"Knolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Heikenw\u00e4lder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2023.02.033_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.02.033_bib2","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.02.033_bib3","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.jhep.2023.02.033_bib4","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/obr.12407","article-title":"Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies","volume":"17","author":"Li","year":"2016","journal-title":"Obes Rev"},{"key":"10.1016\/j.jhep.2023.02.033_bib5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/hep.28697","article-title":"Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients","volume":"65","author":"Leung","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.02.033_bib6","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/sj.bjc.6603932","article-title":"Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies","volume":"97","author":"Larsson","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jhep.2023.02.033_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1034\/j.1600-0528.2002.017408.x","article-title":"Local control of the immune response in the liver","volume":"174","author":"Knolle","year":"2000","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jhep.2023.02.033_bib8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1126\/scitranslmed.3008618","article-title":"The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota","volume":"6","author":"Balmer","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jhep.2023.02.033_bib9","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1126\/science.aad0135","article-title":"A\u00a0gut-vascular barrier controls the systemic dissemination of bacteria","volume":"350","author":"Spadoni","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jhep.2023.02.033_bib10","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nri2858","article-title":"Antigen-presenting cell function in the tolerogenic liver environment","volume":"10","author":"Thomson","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhep.2023.02.033_bib11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1146\/annurev.immunol.021908.132629","article-title":"The liver as a lymphoid organ","volume":"27","author":"Crispe","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jhep.2023.02.033_bib12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev-immunol-051116-052415","article-title":"Immune responses in the liver","volume":"36","author":"Kubes","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jhep.2023.02.033_bib13","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41590-018-0044-z","article-title":"The immunology of hepatocellular carcinoma","volume":"19","author":"Ringelhan","year":"2018","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2023.02.033_bib14","first-page":"89","article-title":"The acute phase response of the liver in inflammation","volume":"9","author":"Fey","year":"1990","journal-title":"Prog Liver Dis"},{"key":"10.1016\/j.jhep.2023.02.033_bib15","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/bj2650621","article-title":"Interleukin-6 and the acute phase response","volume":"265","author":"Heinrich","year":"1990","journal-title":"Biochem J"},{"key":"10.1016\/j.jhep.2023.02.033_bib16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/archsurg.1992.01420010037006","article-title":"Liver nonparenchymal cells are stimulated to provide interleukin 6 for induction of the hepatic acute-phase response in endotoxemia but not in remote localized inflammation","volume":"127","author":"Billiar","year":"1992","journal-title":"Arch Surg"},{"key":"10.1016\/j.jhep.2023.02.033_bib17","first-page":"339","article-title":"Characterization of pattern recognition receptor expression and functionality in liver primary cells and derived cell lines","volume":"10","author":"Faure-Dupuy","year":"2018","journal-title":"J\u00a0Innate Immun"},{"key":"10.1016\/j.jhep.2023.02.033_bib18","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s42255-019-0044-9","article-title":"Liver macrophages regulate systemic metabolism through non-inflammatory factors","volume":"1","author":"Morgantini","year":"2019","journal-title":"Nat Metab"},{"key":"10.1016\/j.jhep.2023.02.033_bib19","doi-asserted-by":"crossref","DOI":"10.1172\/JCI135197","article-title":"TREM2 sustains macrophage-hepatocyte metabolic coordination in nonalcoholic fatty liver disease and sepsis","volume":"131","author":"Hou","year":"2021","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhep.2023.02.033_bib20","doi-asserted-by":"crossref","first-page":"R1217","DOI":"10.1152\/ajpregu.00686.2011","article-title":"The scavenger endothelial cell: a new player in homeostasis and immunity","volume":"303","author":"Sorensen","year":"2012","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.jhep.2023.02.033_bib21","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1172\/JCI200421593","article-title":"The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity","volume":"114","author":"Bowen","year":"2004","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhep.2023.02.033_bib22","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1053\/j.gastro.2008.05.076","article-title":"B7-H1 on hepatocytes facilitates priming of specific CD8 T cells but limits the specific recall of primed responses","volume":"135","author":"Wahl","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2023.02.033_bib23","doi-asserted-by":"crossref","first-page":"16735","DOI":"10.1073\/pnas.1112251108","article-title":"Hepatocyte entry leads to degradation of autoreactive CD8 T cells","volume":"108","author":"Benseler","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2023.02.033_bib24","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jhep.2023.02.033_bib25","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.02.033_bib26","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41590-020-0666-9","article-title":"Regulatory myeloid cells paralyze T cells through cell-cell transfer of the metabolite methylglyoxal","volume":"21","author":"Baumann","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2023.02.033_bib27","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41575-018-0020-y","article-title":"Liver sinusoidal endothelial cells - gatekeepers of hepatic immunity","volume":"15","author":"Shetty","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.02.033_bib28","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/82161","article-title":"Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance","volume":"6","author":"Limmer","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2023.02.033_bib29","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.celrep.2013.02.008","article-title":"Liver-primed memory T cells generated under noninflammatory conditions provide anti-infectious immunity","volume":"3","author":"Bottcher","year":"2013","journal-title":"Cell Rep"},{"key":"10.1016\/j.jhep.2023.02.033_bib30","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.celrep.2014.07.008","article-title":"IL-6 trans-signaling-dependent rapid development of cytotoxic CD8+ T cell function","volume":"8","author":"Bottcher","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.jhep.2023.02.033_bib31","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1038\/cti.2016.74","article-title":"The role of liver sinusoidal cells in local hepatic immune surveillance","volume":"5","author":"Wohlleber","year":"2016","journal-title":"Clin Transl Immunol"},{"key":"10.1016\/j.jhep.2023.02.033_bib32","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/hep.27376","article-title":"Liver sinusoidal endothelial cells in hepatic fibrosis","volume":"61","author":"DeLeve","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.02.033_bib33","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/s41591-021-01344-3","article-title":"XCR1(+) type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis","volume":"27","author":"Deczkowska","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2023.02.033_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.757469","article-title":"The scavenger function of liver sinusoidal endothelial cells in health and disease","volume":"12","author":"Bhandari","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.jhep.2023.02.033_bib35","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.immuni.2016.08.011","article-title":"Liver-resident memory CD8(+) T cells form a front-line defense against malaria liver-stage infection","volume":"45","author":"Fernandez-Ruiz","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2023.02.033_bib36","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nri.2017.11","article-title":"Liver macrophages in tissue homeostasis and disease","volume":"17","author":"Krenkel","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhep.2023.02.033_bib37","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.immuni.2016.02.024","article-title":"Tissue-resident macrophage ontogeny and homeostasis","volume":"44","author":"Ginhoux","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2023.02.033_bib38","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cell.2021.12.018","article-title":"Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches","volume":"185","author":"Guilliams","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2023.02.033_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10321","article-title":"Bone marrow-derived monocytes give rise to self-renewing and fully differentiated Kupffer cells","volume":"7","author":"Scott","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2023.02.033_bib40","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.immuni.2019.08.017","article-title":"Stellate cells, hepatocytes, and endothelial cells imprint the kupffer cell identity on monocytes colonizing the liver macrophage niche","volume":"51","author":"Bonnardel","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2023.02.033_bib41","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0168-8278(95)80433-1","article-title":"Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge","volume":"22","author":"Knolle","year":"1995","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.02.033_bib42","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/hep.27793","article-title":"Liver inflammation abrogates immunological tolerance induced by Kupffer cells","volume":"62","author":"Heymann","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.02.033_bib43","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrgastro.2015.200","article-title":"Immunology in the liver--from homeostasis to disease","volume":"13","author":"Heymann","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.02.033_bib44","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1038\/s41467-018-07213-x","article-title":"Perforin inhibition protects from lethal endothelial damage during fulminant viral hepatitis","volume":"9","author":"Welz","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2023.02.033_bib45","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1038\/s41467-021-24734-0","article-title":"CD8(+)\u00a0tissue-resident memory T cells promote liver fibrosis resolution\u00a0by\u00a0inducing apoptosis of hepatic stellate cells","volume":"12","author":"Koda","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2023.02.033_bib46","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ccr.2014.07.001","article-title":"ER stress cooperates with hypernutrition to trigger TNF-dependent spontaneous HCC development","volume":"26","author":"Nakagawa","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jhep.2023.02.033_bib47","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cell.2018.08.020","article-title":"ER stress drives lipogenesis and steatohepatitis via caspase-2 activation of S1P","volume":"175","author":"Kim","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2023.02.033_bib48","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41591-019-0379-5","article-title":"Platelet GPIbalpha is a mediator and potential interventional target for NASH and subsequent liver cancer","volume":"25","author":"Malehmir","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2023.02.033_bib49","doi-asserted-by":"crossref","first-page":"E2165","DOI":"10.1073\/pnas.1209182109","article-title":"Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B","volume":"109","author":"Sitia","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2023.02.033_bib50","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jhep.2013.05.040","article-title":"Anti-platelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma","volume":"59","author":"Sitia","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.02.033_bib51","article-title":"Regular aspirin use is associated with a reduced risk of hepatocellular carcinoma (HCC) in chronic liver disease: a systematic review and meta-analysis","author":"Tan","year":"2022","journal-title":"J Gastrointest Cancer"},{"key":"10.1016\/j.jhep.2023.02.033_bib52","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa1912035","article-title":"Association of aspirin with hepatocellular carcinoma and liver-related mortality","volume":"382","author":"Simon","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2023.02.033_bib53","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jhepr.2019.10.001","article-title":"Platelets in chronic liver disease, from bench to bedside","volume":"1","author":"Ramadori","year":"2019","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2023.02.033_bib54","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1016\/j.cgh.2019.04.061","article-title":"Daily aspirin use associated with reduced risk for fibrosis progression in patients with nonalcoholic fatty liver disease","volume":"17","author":"Simon","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.02.033_bib55","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2023.02.033_bib56","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","article-title":"Immunotherapies for hepatocellular carcinoma","volume":"19","author":"Llovet","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"issue":"Suppl 4","key":"10.1016\/j.jhep.2023.02.033_bib57","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/jgh.12244","article-title":"Role of diet and nutritional management in non-alcoholic fatty liver disease","volume":"28","author":"Fan","year":"2013","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.02.033_bib58","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00125-016-3933-4","article-title":"Adipose tissue plasticity: how fat depots respond differently to pathophysiological cues","volume":"59","author":"Pellegrinelli","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.jhep.2023.02.033_bib59","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1371\/journal.pbio.0060237","article-title":"It's not how fat you are, it's what you do with it that counts","volume":"6","author":"Virtue","year":"2008","journal-title":"Plos Biol"},{"key":"10.1016\/j.jhep.2023.02.033_bib60","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.gtc.2019.09.003","article-title":"Nutrition and nonalcoholic fatty liver disease: current perspectives","volume":"49","author":"Chakravarthy","year":"2020","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.jhep.2023.02.033_bib61","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature21363","article-title":"Inflammation, metaflammation and immunometabolic disorders","volume":"542","author":"Hotamisligil","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2023.02.033_bib62","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1194\/jlr.R066514","article-title":"Lipid signaling and lipotoxicity in metaflammation: indications for metabolic disease pathogenesis and treatment","volume":"57","author":"Ertunc","year":"2016","journal-title":"J\u00a0Lipid Res"},{"issue":"Suppl 2","key":"10.1016\/j.jhep.2023.02.033_bib63","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1463-1326.2010.01275.x","article-title":"Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c","volume":"12","author":"Ferre","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jhep.2023.02.033_bib64","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S1097-2765(00)80150-1","article-title":"Molecular identification of the sterol-regulated luminal protease that cleaves SREBPs and controls lipid composition of animal cells","volume":"2","author":"Sakai","year":"1998","journal-title":"Mol Cell"},{"key":"10.1016\/j.jhep.2023.02.033_bib65","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","article-title":"Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease","volume":"146","author":"Lambert","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2023.02.033_bib66","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nature13478","article-title":"The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes","volume":"510","author":"Perry","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2023.02.033_bib67","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1007\/s10620-016-4054-0","article-title":"Role of dietary fructose and hepatic de novo lipogenesis in fatty liver disease","volume":"61","author":"Softic","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2023.02.033_bib68","doi-asserted-by":"crossref","first-page":"5679","DOI":"10.3390\/nu6125679","article-title":"The role of dietary sugars and de novo\u00a0lipogenesis in non-alcoholic fatty liver disease","volume":"6","author":"Moore","year":"2014","journal-title":"Nutrients"},{"key":"10.1016\/j.jhep.2023.02.033_bib69","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1172\/JCI86013","article-title":"Insulin receptor Thr1160 phosphorylation mediates lipid-induced hepatic insulin resistance","volume":"126","author":"Petersen","year":"2016","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhep.2023.02.033_bib70","doi-asserted-by":"crossref","first-page":"16381","DOI":"10.1073\/pnas.1113359108","article-title":"Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease","volume":"108","author":"Kumashiro","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2023.02.033_bib71","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.celrep.2017.05.035","article-title":"Hepatic diacylglycerol-associated protein kinase cepsilon translocation links hepatic steatosis to hepatic insulin resistance in humans","volume":"19","author":"Ter Horst","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.jhep.2023.02.033_bib72","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/00365520701559003","article-title":"Blood oxidative stress markers in non-alcoholic steatohepatitis and how it correlates with diet","volume":"43","author":"Machado","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2023.02.033_bib73","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1055\/s-0028-1091980","article-title":"Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease","volume":"28","author":"Malhi","year":"2008","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2023.02.033_bib74","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/hep.25539","article-title":"Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease","volume":"55","author":"Lomonaco","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.02.033_bib75","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s00125-005-1682-x","article-title":"Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms","volume":"48","author":"Bugianesi","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.jhep.2023.02.033_bib76","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/joim.12540","article-title":"Adipose tissue regulates insulin sensitivity: role of adipogenesis, de novo lipogenesis and novel lipids","volume":"280","author":"Smith","year":"2016","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jhep.2023.02.033_bib77","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41580-021-00390-6","article-title":"The aetiology and molecular landscape of insulin resistance","volume":"22","author":"James","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jhep.2023.02.033_bib78","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1172\/JCI7535","article-title":"Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle","volume":"105","author":"Cusi","year":"2000","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhep.2023.02.033_bib79","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1074\/jbc.M101521200","article-title":"Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action","volume":"277","author":"Aguirre","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jhep.2023.02.033_bib80","doi-asserted-by":"crossref","first-page":"9047","DOI":"10.1074\/jbc.275.12.9047","article-title":"The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307)","volume":"275","author":"Aguirre","year":"2000","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jhep.2023.02.033_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/cells9030706","article-title":"Role of c-jun N-terminal kinase (JNK) in obesity and type 2 diabetes","volume":"9","author":"Yung","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jhep.2023.02.033_bib82","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3389\/fphys.2018.00132","article-title":"Key inflammatory processes in human NASH are reflected in Ldlr(-\/-).Leiden mice: a translational gene profiling study","volume":"9","author":"Morrison","year":"2018","journal-title":"Front Physiol"},{"key":"10.1016\/j.jhep.2023.02.033_bib83","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","article-title":"Mechanisms of insulin action and insulin resistance","volume":"98","author":"Petersen","year":"2018","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jhep.2023.02.033_bib84","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhep.2023.02.033_bib85","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1172\/JCI29069","article-title":"Inflammation and insulin resistance","volume":"116","author":"Shoelson","year":"2006","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhep.2023.02.033_bib86","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41575-019-0212-0","article-title":"Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology","volume":"17","author":"Eslam","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.02.033_bib87","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.jhep.2020.02.020","article-title":"Update on NAFLD genetics: from new variants to the clinic","volume":"72","author":"Trepo","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.02.033_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3350\/cmh.2016.0109","article-title":"Genetic predisposition in nonalcoholic fatty liver disease","volume":"23","author":"Sookoian","year":"2017","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jhep.2023.02.033_bib89","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2023.02.033_bib90","doi-asserted-by":"crossref","first-page":"6706","DOI":"10.1074\/jbc.M109.064501","article-title":"A\u00a0sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis","volume":"285","author":"He","year":"2010","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jhep.2023.02.033_bib91","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1093\/hmg\/ddu121","article-title":"PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells","volume":"23","author":"Pirazzi","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jhep.2023.02.033_bib92","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jhep.2014.02.030","article-title":"Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma","volume":"61","author":"Liu","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.02.033_bib93","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng.2901","article-title":"Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease","volume":"46","author":"Kozlitina","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2023.02.033_bib94","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1093\/hmg\/ddp357","article-title":"The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver","volume":"18","author":"Beer","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jhep.2023.02.033_bib95","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/hep.24806","article-title":"Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents","volume":"55","author":"Santoro","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.02.033_bib96","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1056\/NEJMra1600266","article-title":"The human intestinal microbiome in health and disease","volume":"375","author":"Lynch","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2023.02.033_bib97","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jhep.2017.11.014","article-title":"Lipotoxicity and the gut-liver axis in NASH pathogenesis","volume":"68","author":"Marra","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.02.033_bib98","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrgastro.2010.172","article-title":"The role of the gut microbiota in nonalcoholic fatty liver disease","volume":"7","author":"Abu-Shanab","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.02.033_bib99","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nrgastro.2016.85","article-title":"The role of the gut microbiota in NAFLD","volume":"13","author":"Leung","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.02.033_bib100","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/gut.48.2.206","article-title":"The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis","volume":"48","author":"Wigg","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2023.02.033_bib101","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","article-title":"Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders","volume":"17","author":"Aron-Wisnewsky","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.02.033_bib102","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/hep.22848","article-title":"Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease","volume":"49","author":"Miele","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.02.033_bib103","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1126\/science.1698311","article-title":"CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein","volume":"249","author":"Wright","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.jhep.2023.02.033_bib104","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10809","article-title":"Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity","volume":"482","author":"Henao-Mejia","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2023.02.033_bib105","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/j.1572-0241.2001.03702.x","article-title":"Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of nonalcoholic steatohepatitis","volume":"96","author":"Nair","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2023.02.033_bib106","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1572-0241.1999.00797.x","article-title":"Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage","volume":"94","author":"Keshavarzian","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2023.02.033_bib107","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S0168-8278(00)80242-1","article-title":"Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease","volume":"32","author":"Parlesak","year":"2000","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.02.033_bib108","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1194\/jlr.M016246","article-title":"Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice","volume":"52","author":"Subramanian","year":"2011","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jhep.2023.02.033_bib109","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1128\/JB.188.5.1979-1986.2006","article-title":"Mechanism of growth inhibition by free bile acids in lactobacilli and bifidobacteria","volume":"188","author":"Kurdi","year":"2006","journal-title":"J\u00a0Bacteriol"},{"key":"10.1016\/j.jhep.2023.02.033_bib110","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1172\/JCI25604","article-title":"Farnesoid X receptor is essential for normal glucose homeostasis","volume":"116","author":"Ma","year":"2006","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhep.2023.02.033_bib111","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s12072-010-9202-6","article-title":"Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease","volume":"4","author":"Yang","year":"2010","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2023.02.033_bib112","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2009.08.001","article-title":"TGR5-mediated bile acid sensing controls glucose homeostasis","volume":"10","author":"Thomas","year":"2009","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2023.02.033_bib113","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093567","article-title":"GPBAR1\/TGR5 mediates bile acid-induced cytokine expression in murine Kupffer cells","volume":"9","author":"Lou","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2023.02.033_bib114","doi-asserted-by":"crossref","DOI":"10.1128\/mSystems.00070-16","article-title":"Farnesoid X receptor signaling shapes the gut microbiota and controls hepatic lipid metabolism","volume":"1","author":"Zhang","year":"2016","journal-title":"mSystems"},{"key":"10.1016\/j.jhep.2023.02.033_bib115","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.freeradbiomed.2013.08.174","article-title":"Free radical biology for medicine: learning from nonalcoholic fatty liver disease","volume":"65","author":"Serviddio","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jhep.2023.02.033_bib116","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jhep.2023.02.033_bib117","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1053\/j.gastro.2014.07.018","article-title":"Cell death and cell death responses in liver disease: mechanisms and clinical relevance","volume":"147","author":"Luedde","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2023.02.033_bib118","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1053\/j.gastro.2019.11.311","article-title":"Mechanisms of fibrosis development in nonalcoholic steatohepatitis","volume":"158","author":"Schwabe","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2023.02.033_bib119","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1002\/hep.26511","article-title":"Cross-talk between Notch and Hedgehog regulates hepatic stellate cell fate in mice","volume":"58","author":"Xie","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.02.033_bib120","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.cmet.2016.09.016","article-title":"Hepatocyte TAZ\/WWTR1 promotes inflammation and fibrosis in nonalcoholic steatohepatitis","volume":"24","author":"Wang","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2023.02.033_bib121","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1055\/s-0040-1708540","article-title":"The NLRP3 inflammasome in alcoholic and nonalcoholic steatohepatitis","volume":"40","author":"Knorr","year":"2020","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2023.02.033_bib122","doi-asserted-by":"crossref","first-page":"15324","DOI":"10.1073\/pnas.1100255108","article-title":"Inflammasome is a central player in the induction of obesity and insulin resistance","volume":"108","author":"Stienstra","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2023.02.033_bib123","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","article-title":"NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice","volume":"66","author":"Mridha","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.02.033_bib124","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1126\/science.1179721","article-title":"Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5","volume":"328","author":"Vijay-Kumar","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jhep.2023.02.033_bib125","doi-asserted-by":"crossref","first-page":"G483","DOI":"10.1152\/ajpgi.00213.2017","article-title":"CC chemokine receptor 2 promotes recruitment of myeloid cells associated with insulin resistance in nonalcoholic fatty liver disease","volume":"314","author":"Parker","year":"2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2023.02.033_bib126","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1007\/s10620-016-4049-x","article-title":"Innate immunity and inflammation in NAFLD\/NASH","volume":"61","author":"Arrese","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2023.02.033_bib127","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jhep.2020.04.033","article-title":"Danger signals in liver injury and restoration of homeostasis","volume":"73","author":"Han","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.02.033_bib128","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI76887","article-title":"The HMGB1\/RAGE axis triggers neutrophil-mediated injury amplification following necrosis","volume":"125","author":"Huebener","year":"2015","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhep.2023.02.033_bib129","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.3389\/fimmu.2019.01478","article-title":"Platelet inflammatory response to stress","volume":"10","author":"Cognasse","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2023.02.033_bib130","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12072-018-9911-9","article-title":"DAMPs and sterile inflammation in drug hepatotoxicity","volume":"13","author":"Yang","year":"2019","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2023.02.033_bib131","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jcmgh.2021.11.009","article-title":"Hepatocytes are resistant to cell death from canonical and non-canonical inflammasome-activated pyroptosis","volume":"13","author":"Sun","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.02.033_bib132","doi-asserted-by":"crossref","first-page":"536","DOI":"10.15252\/embj.201591857","article-title":"p38gamma and p38delta reprogram liver metabolism by modulating neutrophil infiltration","volume":"35","author":"Gonzalez-Teran","year":"2016","journal-title":"EMBO J"},{"key":"10.1016\/j.jhep.2023.02.033_bib133","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.1172\/JCI122258","article-title":"Neutrophils contribute to spontaneous resolution of liver inflammation and fibrosis via microRNA-223","volume":"129","author":"Calvente","year":"2019","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhep.2023.02.033_bib134","doi-asserted-by":"crossref","first-page":"G211","DOI":"10.1152\/ajpgi.00040.2019","article-title":"CD8(+) T cells regulate liver injury in obesity-related nonalcoholic fatty liver disease","volume":"318","author":"Breuer","year":"2020","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2023.02.033_bib135","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-021-03362-0","article-title":"NASH limits anti-tumour surveillance in immunotherapy-treated HCC","volume":"592","author":"Pfister","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2023.02.033_bib136","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s42255-019-0076-1","article-title":"Transcriptional network analysis implicates altered hepatic immune\u00a0function in NASH development and resolution","volume":"1","author":"Haas","year":"2019","journal-title":"Nat Metab"},{"key":"10.1016\/j.jhep.2023.02.033_bib137","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41586-021-03233-8","article-title":"Auto-aggressive CXCR6(+) CD8 T cells cause liver immune pathology in NASH","volume":"592","author":"Dudek","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2023.02.033_bib138","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nature16969","article-title":"NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis","volume":"531","author":"Ma","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2023.02.033_bib139","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ccell.2016.05.020","article-title":"Metabolic inflammation-associated IL-17A causes non-alcoholic steatohepatitis and hepatocellular carcinoma","volume":"30","author":"Gomes","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jhep.2023.02.033_bib140","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4049\/jimmunol.1501175","article-title":"Progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis is marked by a higher frequency of Th17 cells in the liver and an increased Th17\/resting regulatory T cell ratio in peripheral blood and in the liver","volume":"196","author":"Rau","year":"2016","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhep.2023.02.033_bib141","article-title":"Single-cell and bulk transcriptomics of the liver reveals potential targets of NASH with fibrosis","volume":"11","author":"Wang","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2023.02.033_bib142","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ccell.2014.09.003","article-title":"Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes","volume":"26","author":"Wolf","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jhep.2023.02.033_bib143","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.640869","article-title":"Revisiting the role of natural killer cells in non-alcoholic fatty liver disease","volume":"12","author":"Martinez-Chantar","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2023.02.033_bib144","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.3389\/fimmu.2018.01994","article-title":"Mucosal-associated invariant T cells improve nonalcoholic fatty liver disease through regulating macrophage polarization","volume":"9","author":"Li","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2023.02.033_bib145","article-title":"The microbiota maintain homeostasis of liver-resident gammadeltaT-17 cells in a lipid antigen\/CD1d-dependent manner","volume":"7","author":"Li","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2023.02.033_bib146","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s12072-020-10081-7","article-title":"The role of neutrophils in innate immunity-driven nonalcoholic steatohepatitis: lessons learned and future promise","volume":"14","author":"Wu","year":"2020","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2023.02.033_bib147","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cyto.2016.01.020","article-title":"Interleukin-15-mediated inflammation promotes non-alcoholic fatty liver disease","volume":"82","author":"Cepero-Donates","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.jhep.2023.02.033_bib148","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/s12276-020-0480-3","article-title":"Immunological distinctions between nonalcoholic steatohepatitis and hepatocellular carcinoma","volume":"52","author":"Koo","year":"2020","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.jhep.2023.02.033_bib149","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jhep.2021.04.049","article-title":"Corrigendum to 'Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis'","volume":"75","author":"Pinyol","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.02.033_bib150","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ccell.2017.08.010","article-title":"A\u00a0dual role of caspase-8 in triggering and sensing proliferation-associated DNA damage, a key determinant of liver cancer development","volume":"32","author":"Boege","year":"2017","journal-title":"Cancer Cell"},{"issue":"14","key":"10.1016\/j.jhep.2023.02.033_bib151","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.devcel.2022.06.003","article-title":"Replication stress triggered by nucleotide pool imbalance drives DNA damage and cGAS-STING pathway activation in NAFLD","volume":"57","author":"Donne","year":"2022","journal-title":"Dev Cell"},{"key":"10.1016\/j.jhep.2023.02.033_bib152","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000443344","article-title":"European association for the study of the L, European association for the study of D, European association for the study of O. EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease","volume":"9","year":"2016","journal-title":"Obes Facts"},{"key":"10.1016\/j.jhep.2023.02.033_bib153","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hep.23276","article-title":"Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis","volume":"51","author":"Promrat","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.02.033_bib154","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2023.02.033_bib155","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jhep.2011.08.018","article-title":"Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"56","author":"Parker","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.02.033_bib156","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMoa1200303","article-title":"Primary prevention of cardiovascular disease with a Mediterranean diet","volume":"368","author":"Estruch","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2023.02.033_bib157","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.clnu.2013.08.014","article-title":"Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease","volume":"33","author":"Kontogianni","year":"2014","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jhep.2023.02.033_bib158","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2337\/db08-1220","article-title":"Endoplasmic reticulum stress is reduced in tissues of obese subjects after weight loss","volume":"58","author":"Gregor","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.jhep.2023.02.033_bib159","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.23280","article-title":"Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications","volume":"51","author":"Fabbrini","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.02.033_bib160","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1159\/000442721","article-title":"European guidelines for obesity management in adults","volume":"8","author":"Yumuk","year":"2015","journal-title":"Obes Facts"},{"key":"10.1016\/j.jhep.2023.02.033_bib161","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.cell.2016.09.014","article-title":"Chemical hybridization of glucagon and thyroid hormone optimizes therapeutic impact for metabolic disease","volume":"167","author":"Finan","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2023.02.033_bib162","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2023.02.033_bib163","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2337\/dc06-2032","article-title":"Habitual physical activity is associated with intrahepatic fat content in humans","volume":"30","author":"Perseghin","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jhep.2023.02.033_bib164","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2017-000139","article-title":"Efficacy of dietary and physical activity intervention in non-alcoholic fatty liver disease: a systematic review","volume":"4","author":"Kenneally","year":"2017","journal-title":"BMJ Open Gastroenterol"},{"key":"10.1016\/j.jhep.2023.02.033_bib165","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jhep.2011.06.010","article-title":"Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review","volume":"56","author":"Thoma","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.02.033_bib166","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/MEG.0000000000000348","article-title":"Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease","volume":"27","author":"Gangarapu","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.02.033_bib167","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/01.mcg.0000165671.25272.0f","article-title":"Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases","volume":"39","author":"Loguercio","year":"2005","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2023.02.033_bib168","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3945\/ajcn.113.068890","article-title":"Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study","volume":"99","author":"Eslamparast","year":"2014","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jhep.2023.02.033_bib169","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2217\/fmb.15.13","article-title":"Systematic review on intervention with prebiotics\/probiotics in patients with obesity-related nonalcoholic fatty liver disease","volume":"10","author":"Tarantino","year":"2015","journal-title":"Future Microbiol"},{"key":"10.1016\/j.jhep.2023.02.033_bib170","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s00535-019-01649-8","article-title":"Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives","volume":"55","author":"Hu","year":"2020","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jhep.2023.02.033_bib171","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/hep.28709","article-title":"Bile acids and nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives","volume":"65","author":"Arab","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.02.033_bib172","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.molmet.2018.01.005","article-title":"Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR","volume":"9","author":"Jadhav","year":"2018","journal-title":"Mol Metab"},{"key":"10.1016\/j.jhep.2023.02.033_bib173","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.bbagrm.2016.03.002","article-title":"Nuclear receptors and nonalcoholic fatty liver disease","volume":"1859","author":"Cave","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhep.2023.02.033_bib174","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1172\/JCI21025","article-title":"Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c","volume":"113","author":"Watanabe","year":"2004","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhep.2023.02.033_bib175","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1053\/j.gastro.2013.05.042","article-title":"Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease","volume":"145","author":"Mudaliar","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2023.02.033_bib176","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2023.02.033_bib177","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"Electronic address eee, European association for the study of the L. EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.02.033_bib178","doi-asserted-by":"crossref","first-page":"563","DOI":"10.6004\/jnccn.2017.0059","article-title":"NCCN guidelines insights: hepatobiliary cancers, version 1.2017","volume":"15","author":"Benson","year":"2017","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.jhep.2023.02.033_bib179","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jhep.2023.02.033_bib180","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41575-019-0179-x","article-title":"Insights into the success and failure of systemic therapy for hepatocellular carcinoma","volume":"16","author":"Bruix","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.02.033_bib181","doi-asserted-by":"crossref","first-page":"385","DOI":"10.21037\/atm.2017.06.11","article-title":"Molecular mechanisms of programmed cell death-1 dependent T cell suppression: relevance for immunotherapy","volume":"5","author":"Zuazo","year":"2017","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jhep.2023.02.033_bib182","article-title":"Tremelimumab plus durvalumab in unresectable hepatocellular carcinoma","volume":"1","author":"Abou-Alfa Ghassan","year":"2022","journal-title":"NEJM Evid"},{"key":"10.1016\/j.jhep.2023.02.033_bib183","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1038\/s41388-020-1249-9","article-title":"Immune-based therapies for hepatocellular carcinoma","volume":"39","author":"Pinato","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.jhep.2023.02.033_bib184","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","article-title":"Immune checkpoint blockade: a common denominator approach to cancer therapy","volume":"27","author":"Topalian","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jhep.2023.02.033_bib185","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2019.12.002","article-title":"Immunotherapy for hepatocellular carcinoma","volume":"470","author":"Zongyi","year":"2020","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jhep.2023.02.033_bib186","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1053\/j.gastro.2008.03.020","article-title":"A\u00a0new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells","volume":"135","author":"Hoechst","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2023.02.033_bib187","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/hep.26192","article-title":"Monocyte\/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48\/2B4 interactions","volume":"57","author":"Wu","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.02.033_bib188","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1053\/j.gastro.2007.03.102","article-title":"Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients","volume":"132","author":"Fu","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2023.02.033_bib189","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2023.02.033_bib190","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2021.11.030","article-title":"Updated efficacy and safety data from IMbrave150: atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma","volume":"76","author":"Cheng","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.02.033_bib191","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000496277","article-title":"Combination cancer immunotherapy with molecular targeted Agents\/anti-CTLA-4 antibody for hepatocellular carcinoma","volume":"8","author":"Kudo","year":"2019","journal-title":"Liver Cancer"},{"key":"10.1016\/j.jhep.2023.02.033_bib192","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1158\/1078-0432.CCR-18-1543","article-title":"The intersection between tumor Angiogenesis and immune suppression","volume":"25","author":"Rahma","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jhep.2023.02.033_bib193","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.02.033_bib194","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMoa1717002","article-title":"Cabozantinib in patients with advanced and progressing hepatocellular carcinoma","volume":"379","author":"Abou-Alfa","year":"2018","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jhep.2023.02.033_bib195","article-title":"LBA34 - primary results from the phase III LEAP-002 study: lenvatinib plus pembrolizumab versus lenvatinib as first-line (1L) therapy for advanced hepatocellular carcinoma (aHCC)","author":"Finn MK","year":"2022","journal-title":"Annals Oncology"},{"key":"10.1016\/j.jhep.2023.02.033_bib196","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100591","article-title":"Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis","volume":"7","author":"Rimini","year":"2022","journal-title":"ESMO Open"},{"issue":"10","key":"10.1016\/j.jhep.2023.02.033_bib197","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1136\/gutjnl-2021-326259","article-title":"CXCR2 inhibition enables NASH-HCC immunotherapy","volume":"71","author":"Leslie","year":"2022","journal-title":"Gut"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827823001654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827823001654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:52:33Z","timestamp":1759175553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827823001654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":197,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0168827823001654"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2023.02.033","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of immune responses in the development of NAFLD-associated liver cancer and prospects for therapeutic modulation","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2023.02.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}